We have generated a Free Sample of Synthetic, realistic, and 100% customized clinical trial data for the active clinical trials in Australia.
Synthetic Health Data allows companies to speed up and improve software development, helping them to test and validate systems during the whole development process.
The data we provide has different uses:
Below you will find all active clinical trials in Australia and the downloadable Synthetic Health Data we created for each active clinical trial. Feel free to use the search menu if you want to search any specific NCTID, title or sponsor.
|
NCT ID
|
Official Title | Sponsor |
|---|---|---|
| NCT04215809 | Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL | Ascentage Pharma Group Inc. |
| NCT04205227 | ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | ENB Therapeutics, Inc |
| NCT04117854 | Spinal Cord Injury in the Pediatric Population - an International Multicenter Study | Sunnaas Rehabilitation Hospital |
| NCT04094610 | A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations | Turning Point Therapeutics, Inc. |
| NCT04052971 | To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation | Abion Inc |
| NCT04046224 | Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease | Sangamo Therapeutics |
| NCT04029363 | Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk | HighLife SAS |
| NCT04024111 | Social Groups for Australian Children on the Autism Spectrum | Curtin University |
| NCT03980171 | Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma | Peter MacCallum Cancer Centre, Australia |
| NCT03912909 | Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans | Royal Perth Hospital |
| NCT03911505 | ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD | Amicus Therapeutics |
| NCT03906669 | A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. | St Vincent's Hospital |
| NCT03900442 | Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort | Prescient Therapeutics, Ltd. |
| NCT03816397 | Adalimumab in JIA-associated Uveitis Stopping Trial | Nisha Acharya |
| NCT03788811 | ERG Components in Schizophrenia and Bipolar Disorder Type I | diaMentis Inc. |
| NCT03734640 | Optimal Post Tpa-Iv Monitoring in Ischemic Stroke | Craig Anderson |
| NCT03717623 | Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants | Melbourne Health |
| NCT03563053 | Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients With Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study | Erydel |
| NCT03537482 | APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies | Ascentage Pharma Group Inc. |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | Immix Biopharma Australia Pty Ltd |
| NCT03148600 | Rehabilitation After Ileo-anal Pouch Surgery | St Vincent's Hospital Melbourne |
| NCT03050476 | Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase | Alloksys Life Sciences B.V. |
| NCT02984566 | Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) | University of Sydney |
| NCT02629952 | Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes | Menzies Institute for Medical Research |
| NCT02065999 | Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients | Kirby Institute |
| NCT05727189 | A Study of the Safety, Tolerability and Pharmacokinetics of Idazoxan in Healthy Participants | Terran Biosciences Australia Pty Ltd |
| NCT05725291 | AMT-116 in Patients With Selected Advanced Solid Tumors | Multitude Therapeutics Inc. |
| NCT05698277 | Automated Fetal Cardiac Function in Babies Affected by Heart Diseases | Anna Erenbourg |
| NCT05666700 | CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study | Peter MacCallum Cancer Centre, Australia |
| NCT05614258 | Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors | Adagene Inc |
| NCT05583552 | Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy | GCP-Service International West GmbH |
| NCT05568381 | Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention | University of Sydney |
| NCT05528302 | Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment | The University of Queensland |
| NCT05500612 | MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy | University of Sydney |
| NCT05456724 | A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension | Theratocular Biotek Co. |
| NCT05441930 | A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery | PolyActiva Pty Ltd |
| NCT05414747 | Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE) | BioFirst Corporation |
| NCT05169177 | Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy: An Observational Feasibility Study | University of Sydney |
| NCT05152901 | Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults | De Motu Cordis |
| NCT05030207 | Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy | University of Sydney |
| NCT04935762 | A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012) | CuraSen Therapeutics, Inc. |
| NCT04789096 | Tucatinib Together With Pembrolizumab and Trastuzumab | Breast Cancer Trials, Australia and New Zealand |
| NCT03810573 | Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis | Bone Biologics Corp |
| NCT05629559 | 4D-310 in Adults With Fabry Disease and Cardiac Involvement | 4D Molecular Therapeutics |
| NCT05614570 | SSVEP Evaluation of Brain Function | Headsafe MFG |
| NCT05490017 | To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104 | Kira Pharmacenticals (US), LLC. |
| NCT05426746 | First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100 | Aqualung Therapeutics Corp. |
| NCT05367973 | Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women | Daré Bioscience, Inc. |
| NCT05357677 | To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) | Shanghai SIMR Biotechnology Co., Ltd. |
| NCT05151601 | Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism | The University of Queensland |
| NCT05084859 | A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors | Biosplice Therapeutics, Inc. |
| NCT05041114 | SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis | Synchron Medical, Inc. |
| NCT05033483 | Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age? | South Australian Health and Medical Research Institute |
| NCT05017662 | A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 | Ipsen |
| NCT04931862 | Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) | Wave Life Sciences Ltd. |
| NCT04914117 | A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours | RemeGen Co., Ltd. |
| NCT04892524 | Virtual Management of Lung Nodules | Southern Adelaide Local Health Network |
| NCT04849273 | A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC | Turning Point Therapeutics, Inc. |
| NCT04838353 | Alleviate-HF-2 Study | Alleviant Medical, Inc. |
| NCT04778410 | Study of Magrolimab Combinations in Participants With Myeloid Malignancies | Gilead Sciences |
| NCT04774224 | Baricitinib in New-onset Type 1 Diabetes | St Vincent's Institute of Medical Research |
| NCT04739423 | A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders | CuraSen Therapeutics, Inc. |
| NCT04647890 | Effects of FT011 in Systemic Sclerosis | Certa Therapeutics |
| NCT04629443 | Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia | Institut de Recherches Internationales Servier |
| NCT04605978 | Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients | Institut de Recherches Internationales Servier |
| NCT04537832 | Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies | Encoded Therapeutics |
| NCT04529928 | An Initial Evaluation of the Carillon Mitral Contour System for Treatment of Atrial Function Mitral Regurgitation | Cardiac Dimensions Pty Ltd |
| NCT04526704 | Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib | Daiichi Sankyo, Inc. |
| NCT04489368 | Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning | Dr Kundan Singh Chufal |
| NCT04480463 | A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD) | Sam Chun Dang Pharm. Co. Ltd. |
| NCT04455503 | Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1 | Evaxion Biotech A/S |
| NCT04385277 | Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) | Children's Oncology Group |
| NCT04383210 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | Elevation Oncology |
| NCT04354818 | Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) | Kirby Institute |
| NCT04323046 | Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults | Sabine Mueller, MD, PhD |
| NCT04304482 | ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome | Anavex Life Sciences Corp. |
| NCT04300244 | Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma | Åslaug Helland |
| NCT04262336 | Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment | Decibel Therapeutics |
| NCT04234061 | Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma | Peter MacCallum Cancer Centre, Australia |
| NCT04201262 | An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD | Alexion Pharmaceuticals |
| NCT04186637 | An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies | Alpine Immune Sciences, Inc. |
| NCT04154943 | Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma | Regeneron Pharmaceuticals |
| NCT04042025 | Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi | Novartis Gene Therapies |
| NCT03897205 | An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients | Hansa Biopharma AB |
| NCT03894020 | GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) | Gyroscope Therapeutics Limited |
| NCT03763682 | BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea With and Without Complete Concentric Collapse | Nyxoah S.A. |
| NCT03755128 | A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn | Momenta Pharmaceuticals, Inc. |
| NCT03750786 | A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer | Isofol Medical AB |
| NCT03720431 | TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer | PharmAbcine |
| NCT03710876 | Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma | Trizell Ltd |
| NCT03616470 | Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia | GlycoMimetics Incorporated |
| NCT03610061 | A Trial of Radiotherapy and Durvalumab in DLBCL and FL | Austin Health |
| NCT03608670 | Extravascular ICD Pilot Study | Medtronic Cardiac Rhythm and Heart Failure |
| NCT03535740 | A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib | Ariad Pharmaceuticals |
| NCT03430401 | Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia | University of Western Sydney |
| NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | Peter MacCallum Cancer Centre, Australia |
| NCT03277196 | A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation | Vertex Pharmaceuticals Incorporated |
| NCT03245021 | Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A | Dr. Eliza Hawkes |
| NCT03227042 | A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) | Allievex Corporation |
| NCT03177044 | Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease | St Vincent's Hospital Melbourne |
| NCT03148327 | Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy | Jonsson Comprehensive Cancer Center |
| NCT03146468 | Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation | Melbourne Health |
| NCT03136809 | ALS Treatment Extension Study | Collaborative Medicinal Development Pty Limited |
| NCT03113942 | Study of Pomalidomide in Anal Cancer Precursors | Kirby Institute |
| NCT03005327 | A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome | X4 Pharmaceuticals |
| NCT02922036 | Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients | EBR Systems, Inc. |
| NCT02881203 | Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart | University of Sydney |
| NCT02875548 | Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study | Epizyme, Inc. |
| NCT02858921 | Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma | Melanoma Institute Australia |
| NCT02807181 | SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma | Sirtex Medical |
| NCT02708875 | Microvascular Insulin Resistance and Mixed Meal Challenge | Menzies Institute for Medical Research |
| NCT02662062 | Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer | Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
| NCT02613819 | Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney | Trans Tasman Radiation Oncology Group |
| NCT02610660 | Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension | Association for Pediatric Pulmonary Hypertension |
| NCT02302872 | Treatment of Heart Failure and Associated Functional Mitral Valve Regurgitation | Mvrx, Inc. |
| NCT02030964 | N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan | New Approaches to Neuroblastoma Therapy Consortium |
| NCT02004691 | Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency | Genzyme, a Sanofi Company |
| NCT01972347 | Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma | Melanoma Institute Australia |
| NCT01887938 | An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy | Shire |
| NCT01796171 | A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma | Nordic Nanovector |
| NCT01100892 | Cystic Fibrosis - Insulin Deficiency, Early Action | Sydney Children's Hospitals Network |
| NCT00975520 | Neurotropic Melanoma of the Head and Neck | Melanoma and Skin Cancer Trials Limited |
| NCT00653068 | Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System | Children's Oncology Group |
| NCT00319579 | A Prospective Study of Living Kidney Donation | Amit Garg |
| NCT05517564 | First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease | JD Bioscience Inc. |
| NCT05004129 | Safety and Efficacy of Tideglusib in Congenital Myotonic Dystrophy | AMO Pharma Limited |
| NCT04774185 | Hearing Aid Transmitter Performance Study - SRF-366 | Sonova AG |
| NCT03882671 | Development of a Minimally Invasive Seizure Gauge | Seer Medical Pty Ltd |
| NCT03229200 | Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. | Pharmacyclics Switzerland GmbH |
| NCT05710341 | Nitrate INFORMER Water Study | Edith Cowan University |
| NCT05646836 | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma | Genentech, Inc. |
| NCT05638347 | A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. | Atridia Pty Ltd. |
| NCT05636514 | Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS | Clinical Hub for Interventional Research (CHOIR) |
| NCT05635084 | A First-in-human Study of YN001 in Healthy Volunteers | Beijing Inno Medicine Co., Ltd. |
| NCT05621317 | A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy | Aravax Pty Ltd |
| NCT05610176 | BIO|CONCEPT.Amvia Study | Biotronik Australia Pty Ltd. |
| NCT05607498 | First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors | EpimAb Biotherapeutics (Suzhou)Co., Ltd. |
| NCT05605951 | Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve | Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul |
| NCT05587283 | Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women | AtoGen Co. Ltd |
| NCT05570591 | Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy | Nova Eye Medical Pty Ltd. |
| NCT05549219 | 12-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Adults With PMM2-CDG | Glycomine, Inc. |
| NCT05544552 | Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations | Tyra Biosciences, Inc |
| NCT05511922 | PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial | KalVista Pharmaceuticals, Ltd. |
| NCT05501574 | An Open Label Trial Evaluating Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients | TFF Pharmaceuticals, Inc. |
| NCT05494918 | First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors | Alphamab (Australia) Co Pty Ltd. |
| NCT05476770 | Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies | Therapeutic Advances in Childhood Leukemia Consortium |
| NCT05475925 | A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | Dren Bio |
| NCT05473533 | Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects | Pieris Australia Pty Ltd |
| NCT05462223 | Alucent Vessel Restoration System for AVF | Alucent Biomedical |
| NCT05456269 | A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS | Race Oncology Ltd |
| NCT05454020 | A Study of Topical XG004 in Participants With Osteoarthritis of the Knee | Xgene Pharmaceutical Pty Ltd |
| NCT05420077 | Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273 | RVAC Medicines (US), Inc. |
| NCT05411133 | Treatment of ARB202 Advanced Gastrointestinal Cancer Patients | Arbele Pty Ltd |
| NCT05408572 | Study of SON-1010 (IL12-FHAB) in Healthy Adults | Sonnet BioTherapeutics |
| NCT05399654 | A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors | Tallac Therapeutics |
| NCT05397041 | A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers | Bright Minds Biosciences Pty Ltd |
| NCT05385991 | Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally. | ACM Biolabs |
| NCT05374941 | StimAire Sleep Study | StimAire Australia Pty Ltd |
| NCT05360394 | A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula | Singapore General Hospital |
| NCT05355298 | AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer | Amplia Therapeutics Limited |
| NCT05352893 | Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP | AnaptysBio, Inc. |
| NCT05348694 | OsteoPreP: Food Supplements for Postmenopausal Bone Health | Australian Catholic University |
| NCT05344157 | A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis | Xindu Pty Ltd |
| NCT05331300 | A Study to Evaluate the Safety and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis | Lassen Therapeutics 1 PTY LTD |
| NCT05327803 | Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease | AN2 Therapeutics, Inc |
| NCT05325034 | Guideline Oriented Approach To Lipid Lowering In Asia-Pacific | Stephen Nicholls |
| NCT05311176 | A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) | Imugene Limited |
| NCT05308953 | A Phase I Safety Study of NVG-291 in Healthy Adults | NervGen Pharma |
| NCT05307783 | EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging | Merit Medical Systems, Inc. |
| NCT05298306 | A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain | Lateral Pharma Pty Ltd |
| NCT05293184 | The Global Angelman Syndrome Registry | Foundation for Angelman Syndrome Therapeutics, Australia |
| NCT05276570 | Study of ARO-RAGE in Healthy Subjects and Patients With Asthma | Arrowhead Pharmaceuticals |
| NCT05272605 | Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults | University of Melbourne |
| NCT05270876 | Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients | Cochlear |
| NCT05269316 | Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors | Impact Therapeutics, Inc. |
| NCT05268198 | SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects | Global Health Drug Discovery Institute |
| NCT05267626 | Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer | Aulos Bioscience, Inc. |
| NCT05266105 | A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients | Olema Pharmaceuticals, Inc. |
| NCT05258773 | Evaluation of the Presence of SENS-401 in the Perilymph | Sensorion |
| NCT05253417 | The CANabidiol Use for RElief of Short Term Insomnia | Bod Australia |
| NCT05238207 | A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers | Bond Biosciences |
| NCT05233397 | ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Nationwide Children's Hospital |
| NCT05230758 | Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour | Donald Mabbott |
| NCT05227287 | CLARIFY: ADH1 and ADH2 Disease Monitoring Study (DMS) | Calcilytix Therapeutics, Inc., a BridgeBio company |
| NCT05225857 | A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women | Angitia Biopharmaceuticals |
| NCT05220293 | Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream | Oticara Australia PTY LTD |
| NCT05213624 | A Study to Test BI 764198 in People With a Type of Kidney Disease Called Primary Focal Segmental Glomerulosclerosis | Boehringer Ingelheim |
| NCT05208944 | THIO Sequenced With Cemiplimab in Advanced NSCLC | Maia Biotechnology |
| NCT05202379 | CC-42344 Safety Study in Healthy Participants | Cocrystal Pharma, Inc. |
| NCT05200624 | Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study | Center for Eye Research Australia |
| NCT05199753 | Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours | LaNova Australia Pty Limited |
| NCT05194787 | TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease | University of Tasmania |
| NCT05192473 | POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling | Amplitude Vascular Systems, Inc. |
| NCT05185583 | Methylphenidate in Childhood Apraxia of Speech | Murdoch Childrens Research Institute |
| NCT05183646 | A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Dimerix Bioscience Pty Ltd |
| NCT05177809 | RFC1 Natural History Study | Prof. Dr. Matthis Synofzik |
| NCT05165628 | Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers | Cynata Therapeutics Limited |
| NCT05150457 | Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors | Binacea Pharma, Inc. |
| NCT05135052 | Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer. | OncoBeta Therapeutics |
| NCT05130970 | CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis | CSL Behring |
| NCT05114889 | Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis | Biosion, Inc. |
| NCT05109091 | Study of ATH434 in Participants With Multiple System Atrophy | Alterity Therapeutics |
| NCT05099432 | The CARMA Technique Study | Princess Alexandra Hospital, Brisbane, Australia |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY (ABILITY) Study | Medicenna Therapeutics, Inc. |
| NCT05083364 | Study of ARO-C3 in Adult Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria and Complement-Mediated Renal Disease | Arrowhead Pharmaceuticals |
| NCT05081245 | ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) | MapLight Therapeutics |
| NCT05054530 | Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106 | Gmax Biopharm Australia Pty Ltd. |
| NCT05046665 | A Single-centre, Open-label, Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP Study) | South Metropolitan Health Service |
| NCT05041257 | Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) | ImmunoGen, Inc. |
| NCT05032196 | Study of WVE-003 in Patients With Huntington's Disease | Wave Life Sciences Ltd. |
| NCT05030285 | Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment | The University of Queensland |
| NCT05026632 | NPI-002 Intravitreal Implant for the Delay of Cataract Progression | Nacuity Pharmaceuticals, Inc. |
| NCT05025813 | Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma | Queensland Health |
| NCT05013099 | Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies | ImaginAb, Inc. |
| NCT05012423 | FTIH Study of ECC0509 in Healthy Volunteers | Eccanga Pty Ltd |
| NCT05011851 | An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome | Neuren Pharmaceuticals Limited |
| NCT05003141 | PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies | Qilu Puget Sound Biotherapeutics (dba Sound Biologics) |
| NCT04994912 | First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers | Elixiron Immunotherapeutics Inc. |
| NCT04993079 | Clotild® Smart Guidewire System (CSGS) Evaluation in EndovascUlar Thrombectomy Procedure | Sensome |
| NCT04982094 | Counting On U: Towards Better Mental Health | Leanne Saxon |
| NCT04977063 | Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients | Atmo Biosciences Pty Ltd |
| NCT04973137 | A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis | Prothena Biosciences Ltd. |
| NCT04968574 | A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) | Endeavor Biomedicines, Inc. |
| NCT04963140 | Self-Management Of Asthma By Forced Oscillation Technique | Restech Srl |
| NCT04923256 | AAT-APP+: A Novel Brain-training App to Reduce Drinking | Turning Point |
| NCT04919499 | A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment | Boehringer Ingelheim |
| NCT04912856 | An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE | Xenon Pharmaceuticals Inc. |
| NCT04901806 | Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors | Pyramid Biosciences |
| NCT04901078 | A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers | Kinoxis Therapeutics Pty Ltd |
| NCT04898426 | Effect of Enhanced Interactive Text Messages and Phone Instruction on the Quality of Bowel Preparation for Colonoscopy. | Griffith Base Hospital |
| NCT04898348 | A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis | KoBioLabs |
| NCT04894240 | A Study of Monepantel in Individuals With Motor Neurone Disease | PharmAust Ltd |
| NCT04878510 | Non-invasive Ventilation and Dex in Critically Ill Adults | St. Joseph's Healthcare Hamilton |
| NCT04875975 | A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis | UCB Biopharma SRL |
| NCT04875754 | A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis | ICM Biotech Australia Pty Ltd. |
| NCT04867057 | Trichomylin® Safety, Tolerability, and Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation | ZYUS Life Sciences Inc. |
| NCT04840784 | First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML | Shengke Pharmaceuticals Pty Ltd |
| NCT04835805 | A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Atezolizumab in Patients With NRAS-mutant Advanced Melanoma. | Genentech, Inc. |
| NCT04816604 | Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. |
| NCT04801095 | A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | Wellmarker Bio |
| NCT04773782 | A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling | Blueprint Medicines Corporation |
| NCT04764448 | A Study of Belcesiran in Patients With AATLD | Dicerna Pharmaceuticals, Inc. |
| NCT04748510 | Functionally Aligned vs Mechanical Axis Aligned Total Knee Arthroplasty | Perth Hip and Knee |
| NCT04746612 | First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors | Haihe Biopharma Co., Ltd. |
| NCT04735575 | A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| NCT04721756 | Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging | Avid Radiopharmaceuticals |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | Keythera Pharmaceuticals (Australia) Pty Ltd |
| NCT04701281 | Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer | AllVascular |
| NCT04676711 | A Study of GFH312 in Healthy Subjects | GenFleet Therapeutics (Australia) Pty Ltd. |
| NCT04665206 | Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 Gene Mutations | Vivace Therapeutics, Inc |
| NCT04658537 | Advanced Techniques for Single-fraction Palliative Radiotherapy Versus ASPIRE-single | Royal North Shore Hospital |
| NCT04618393 | A Study of EMB-02 in Participants With Advanced Solid Tumors | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| NCT04613921 | Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs | European Foundation for Study of Chronic Liver Failure |
| NCT04611555 | ICF in Cochlear Implant Users | University Hospital, Antwerp |
| NCT04602858 | The SafeTrip Study - Step Training to Reduce Falls in Older Adults | Neuroscience Research Australia |
| NCT04590001 | Effect of the MobiusHD® in Patients With Heart Failure | Vascular Dynamics, Inc. |
| NCT04585100 | FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension | Future Medicine |
| NCT04581512 | Study to Evaluate the Safety and Tolerability of EP0042 | Ellipses Pharma |
| NCT04563026 | A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment | Durect |
| NCT04544410 | A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH | Spruce Biosciences |
| NCT04544293 | Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) | Savara Inc. |
| NCT04525794 | BRight DCB First-in-Human Study | Biotronik CRC Inc. |
| NCT04519645 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures | UCB Biopharma SRL |
| NCT04500587 | Phase 1 First in Human Study of ZN-d5 as a Single Agent | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. |
| NCT04455932 | HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation | Concord Repatriation General Hospital |
| NCT04450732 | Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors | GeneQuantum Healthcare (Suzhou) Co., Ltd. |
| NCT04437368 | EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 | Gyroscope Therapeutics Limited |
| NCT04416516 | Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor | Ascend Biopharmaceuticals Ltd |
| NCT04355689 | Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome | Nacuity Pharmaceuticals, Inc. |
| NCT04322136 | AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion | The University of Western Australia |
| NCT04290299 | Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive | National Cancer Institute, Naples |
| NCT04253301 | Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency | InnoVein |